Meterbolic provides real-time, personalized, point-of-care diagnostics that provide valuable insight into metabolic dysfunction, years ahead of standard tests.  

Our technology measures insulin resistance through the Kraft Test (our primary tool), data from which is fed into a high quality metabolic analytics and visualization for data analysis and reporting.

As we become able to generate larger scale data we aim to find patterns in lifestyle factors which help determine correlation of these fsctors with changes in metabolic health.

Current practice fails to signal early stages of metabolic disease due to the limitations on standard blood testing (fasting glucose, rarely insulin and never post-prandial monitoring of both glucose and insulin (a Kraft test).   

At Meterbolic we strive to make more useful measurements available to clinical Point-of-Care and also in at-home settings. We strongly believe that PP data points are more useful in the early diagnosis of metabolic deterioration